Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)
This completed Japanese trial assessed safety and efficacy of PegIntron plus Rebetol in chronic hepatitis C, excluding genotype 1 with high …
-
CLINICAL_TRIALS trial_result · 2015-01-28Clinical Trial Update: Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C [Phase 3]
This document reports the completion of a Phase 3 safety and efficacy trial comparing Peginterferon Lambda-1a to Peginterferon Alfa-2a plus …
-
CLINICAL_TRIALS withdrawal · 2015-01-28Clinical Trial Update: The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study
The ROLFH study investigating regression of liver fibrosis and risk for hepatocellular carcinoma in chronic hepatitis C and chronic hepatiti…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects [Phase 2]
Phase 2 study of ABT-267 in treatment-naive hepatitis C virus genotype 1 infection completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1) [Phase 1]
Phase 1 multiple-dose trial assessing the safety and preliminary efficacy of MK-2748 in participants with Hepatitis C; the study has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: A Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104AM2)(COMPLETED) [Phase 2]
This is a completed Phase 2 pharmacokinetics/pharmacodynamics study of SCH 900518 in previously untreated subjects with genotype 1 chronic h…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV) [Phase 4]
Phase 4 clinical trial comparing sirolimus versus mycophenolate in liver transplant recipients with recurrent hepatitis C; results were post…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection [Phase 4]
A Phase 4 pilot study evaluating response-guided therapy with pegylated interferon alfa plus ribavirin in patients with hepatitis B and hepa…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection [Phase 2]
Phase 2 clinical trial evaluating the efficacy of pegylated interferon plus ribavirin plus nitazoxanide in patients with Hepatitis C genotyp…
-
CLINICAL_TRIALS research · 2015-01-13Clinical Trial Update: Identification of Hepatitis C Virus (HCV) Specific T Cells
A completed clinical trial update describing the identification of Hepatitis C virus-specific T cells.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients [Phase 4]
Phase 4 clinical trial evaluating pegylated interferon, ribavirin, and telaprevir for Hepatitis C in liver transplant recipients; the study …
-
CLINICAL_TRIALS research · 2015-01-12Clinical Trial Update: A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C
A retrospective real-world study examining treatment outcomes in patients with chronic hepatitis C, with results posted in 2015 and sponsor …
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Two-way Interaction Between Alisporivir and EDP239 [Phase 1]
A Phase 1 study evaluated the pharmacokinetic and safety interaction between alisporivir and EDP239 in Hepatitis C and has completed.
-
CLINICAL_TRIALS withdrawal · 2015-01-09Clinical Trial Update: A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers [Phase 1]
Phase 1 drug interaction study of Boceprevir with amlodipine or diltiazem in healthy volunteers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 [Phase 2]
A Phase 2 randomized study evaluated the safety, tolerability, and antiviral activity of ABT-450, ABT-333, and ABT-072 in Hepatitis C; the t…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection [Phase 2]
This Phase 2 trial assessed the efficacy, safety, and pharmacokinetics of ABT-450/r in combination with ABT-333 and ribavirin in treatment-n…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV) [Phase 2]
Phase 2 trial evaluating safety, tolerability, pharmacokinetics, and antiviral activity of ABT-450/r in combination with ABT-072 and ribavir…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection [Phase 2]
A phase 2 trial evaluated ABT-333 alone and in combination with pegylated interferon and ribavirin for genotype 1 chronic hepatitis C virus …
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects [Phase 2]
Phase 2 study of ABT-267 in adults with chronic hepatitis C infection completed; safety, tolerability, pharmacokinetics, and antiviral activ…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies [Phase 2]
Phase 2 follow-up study evaluating resistance to ABT-333 in hepatitis C patients who previously received ABT-333; results posted 2015-01-08.
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients [Phase 2]
Phase 2 study evaluating paritaprevir/ritonavir with ombitasvir and with or without dasabuvir (± ribavirin) in genotype 1 hepatitis C patien…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine [Phase 2]
An open-label, single-arm Phase 2 study evaluating ABT-450/r/ABT-267 and ABT-333 with ribavirin in adults with genotype 1 chronic hepatitis …
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C [Phase 3]
A Phase 3 trial assessing safety and efficacy of ABT-450/r/ABT-267 and ABT-333 in chronic hepatitis C; study completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection [Phase 3]
Phase 3 trial evaluating treatment for chronic hepatitis C infection in adults with genotype 1b has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis [Phase 3]
Phase 3 study evaluating ABT-450/ritonavir/ABT-267 (ombitasvir) and ABT-333 (dasabuvir) with ribavirin in treatment-experienced adults with …